These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31993931)

  • 41. Premature ovarian failure and fragile X female premutation carriers: no evidence for a skewed X-chromosome inactivation pattern.
    Rodriguez-Revenga L; Madrigal I; Badenas C; Xunclà M; Jiménez L; Milà M
    Menopause; 2009; 16(5):944-9. PubMed ID: 19373114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abnormal GABA-mediated and cerebellar inhibition in women with the fragile X premutation.
    Conde V; Palomar FJ; Lama MJ; Martínez R; Carrillo F; Pintado E; Mir P
    J Neurophysiol; 2013 Mar; 109(5):1315-22. PubMed ID: 23236003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurological signs in the adult with fragile-X premutation].
    Cabanyes-Truffino J
    Neurologia; 2010 May; 25(4):222-7. PubMed ID: 20609299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
    Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
    Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
    Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
    Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome.
    Strom CM; Huang D; Li Y; Hantash FM; Rooke J; Potts SJ; Sun W
    Genet Med; 2007 Apr; 9(4):199-207. PubMed ID: 17438383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered expression of the FMR1 splicing variants landscape in premutation carriers.
    Tseng E; Tang HT; AlOlaby RR; Hickey L; Tassone F
    Biochim Biophys Acta Gene Regul Mech; 2017 Nov; 1860(11):1117-1126. PubMed ID: 28888471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Fragile X premutation: new insights and clinical consequences.
    Van Esch H
    Eur J Med Genet; 2006; 49(1):1-8. PubMed ID: 16473304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FMRpolyG accumulates in FMR1 premutation granulosa cells.
    Friedman-Gohas M; Elizur SE; Dratviman-Storobinsky O; Aizer A; Haas J; Raanani H; Orvieto R; Cohen Y
    J Ovarian Res; 2020 Feb; 13(1):22. PubMed ID: 32101156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective spatial processing deficits in an at-risk subgroup of the fragile X premutation.
    Hocking DR; Kogan CS; Cornish KM
    Brain Cogn; 2012 Jun; 79(1):39-44. PubMed ID: 22417865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Heterogeneity of clinical characteristics of FMR1-related disorders].
    Pereverzeva DS; Tyushkevich SA; Gorbachevskaya NL; Mamokhina UA; Danilina KK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):103-111. PubMed ID: 31464297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The fragile X premutation: into the phenotypic fold.
    Hagerman RJ; Hagerman PJ
    Curr Opin Genet Dev; 2002 Jun; 12(3):278-83. PubMed ID: 12076670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
    Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
    Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.
    McConkie-Rosell A; Abrams L; Finucane B; Cronister A; Gane LW; Coffey SM; Sherman S; Nelson LM; Berry-Kravis E; Hessl D; Chiu S; Street N; Vatave A; Hagerman RJ
    J Genet Couns; 2007 Oct; 16(5):593-606. PubMed ID: 17497108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropathic features in fragile X premutation carriers.
    Berry-Kravis E; Goetz CG; Leehey MA; Hagerman RJ; Zhang L; Li L; Nguyen D; Hall DA; Tartaglia N; Cogswell J; Tassone F; Hagerman PJ
    Am J Med Genet A; 2007 Jan; 143A(1):19-26. PubMed ID: 17152065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A distinct neurocognitive phenotype in female fragile-X premutation carriers assessed with visual attention tasks.
    Steyaert J; Legius E; Borghgraef M; Fryns JP
    Am J Med Genet A; 2003 Jan; 116A(1):44-51. PubMed ID: 12476450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategic Implementation of Fragile X Carrier Screening in China: A Focused Pilot Study.
    Xue J; Zhu Y; Pan Y; Huang H; Wei L; Peng Y; Xi H; Zhou S; Wu H; Gu Z; Huang W; Wang H; Duan R
    J Mol Diagn; 2024 Oct; 26(10):897-905. PubMed ID: 39032823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.